| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,7060 | -0,29% | $1,74B | $125,46K | |
SGRY Surgery Partners, Inc. Common Stock | $13,7060 | +0,19% | $1,74B | $325,69K | |
GAB The Gabelli Equity Trust Inc. | $5,5350 | -1,16% | $1,74B | $468,71K | |
HURN Huron Consulting Group Inc. | $109,59 | +2,25% | $1,74B | $90,74K | |
ENVX Enovix Corporation Common Stock | $7,2610 | -13,20% | $1,74B | $4,70M | |
PAYO Payoneer Global Inc. Common Stock | $4,9540 | -3,43% | $1,74B | $1,56M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,7750 | -1,04% | $1,73B | $90,76K | |
STGW Stagwell Inc. Class A Common Stock | $6,5150 | -2,62% | $1,73B | $221,55K | |
CASH Pathward Financial, Inc. Common Stock | $79,6000 | +0,70% | $1,73B | $64,58K | |
SNDX Syndax Pharmaceuticals, Inc. | $17,6300 | -2,16% | $1,73B | $874,59K | |
STRA Strategic Education, Inc. Common Stock | $82,0800 | +1,91% | $1,73B | $62,43K | |
CAPR Capricor Therapeutics Inc | $27,0540 | -3,21% | $1,73B | $187,90K | |
AAPG Ascentage Pharma Group International American Depository Shares | $17,3000 | -5,36% | $1,73B | $8,78K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8,5350 | -5,59% | $1,73B | $3,61M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $25,4850 | -5,42% | $1,73B | $106,57K | |
